High PSMA Expression is Associated with Immunosuppressive Tumor Microenvironment in Clear Cell Renal Cell Carcinoma

Overview

Journal Precis Clin Med

Publisher Oxford University Press

Specialty General Medicine

Date 2024 May 10

PMID 38726361

Authors

Panagiotis J Vlachostergios

Athanasios Karathanasis

Konstantinos Dimitropoulos

Ioannis Zachos

Vassilios Tzortzis

Affiliations

Soon will be listed here.

References

Baccala A, Sercia L, Li J, Heston W, Zhou M . Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms. Urology. 2007; 70(2):385-90. DOI: 10.1016/j.urology.2007.03.025. View

Li Y, Zheng R, Zhang Y, Huang C, Tian L, Liu R . Special issue "The advance of solid tumor research in China": 68Ga-PSMA-11 PET/CT for evaluating primary and metastatic lesions in different histological subtypes of renal cell carcinoma. Int J Cancer. 2022; 152(1):42-50. PMC: 9796964. DOI: 10.1002/ijc.34189. View

Muselaers S, Erdem S, Bertolo R, Ingels A, Kara O, Pavan N . PSMA PET/CT in Renal Cell Carcinoma: An Overview of Current Literature. J Clin Med. 2022; 11(7). PMC: 8999609. DOI: 10.3390/jcm11071829. View

Spatz S, Tolkach Y, Jung K, Stephan C, Busch J, Ralla B . Comprehensive Evaluation of Prostate Specific Membrane Antigen Expression in the Vasculature of Renal Tumors: Implications for Imaging Studies and Prognostic Role. J Urol. 2017; 199(2):370-377. DOI: 10.1016/j.juro.2017.08.079. View

Wang B, Deng Y, Xu Q, Gao J, Shen H, He X . Exploration of Ga-labelled prostate-specific membrane antigen-11 PET/CT parameters for identifying PBRM1 status in primary clear cell renal cell carcinoma. Clin Radiol. 2023; 78(5):e417-e424. DOI: 10.1016/j.crad.2023.01.003. View

Seront E, Lhommel R, Tombal B . Case Report: Early Ga-PSMA-PET Metabolic Assessment and Response to Systemic Treatment for First-Line Metastatic Clear Cell Renal Cell Carcinoma; About Two Clinical Cases. Front Oncol. 2021; 11:782166. PMC: 8689125. DOI: 10.3389/fonc.2021.782166. View

Raveenthiran S, Esler R, Yaxley J, Kyle S . The use of Ga-PET/CT PSMA in the staging of primary and suspected recurrent renal cell carcinoma. Eur J Nucl Med Mol Imaging. 2019; 46(11):2280-2288. DOI: 10.1007/s00259-019-04432-2. View

Meng L, Zhang S, Gao J, Xu Q, Fu Y, Zhou Y . [Ga]Ga-PSMA-11 PET/CT has potential application in predicting tumor HIF-2α expression and therapeutic response to HIF-2α antagonists in patients with RCC. Eur Radiol. 2022; 32(9):6545-6553. DOI: 10.1007/s00330-022-08738-y. View

Bui V, Unterrainer L, Brendel M, Kunte S, Holzgreve A, Allmendinger F . PSMA-Expression Is Highly Associated with Histological Subtypes of Renal Cell Carcinoma: Potential Implications for Theranostic Approaches. Biomedicines. 2023; 11(11). PMC: 10668989. DOI: 10.3390/biomedicines11113095. View

10.

Gao J, Meng L, Xu Q, Zhao X, Deng Y, Fu Y . Ga-PSMA-11 PET/CT Parameter Correlates with Pathological VEGFR-2/PDGFR-β Expression in Renal Cell Carcinoma Patients. Mol Imaging Biol. 2022; 24(5):759-768. DOI: 10.1007/s11307-022-01725-1. View